Cryotherapy Market Size and Share

Cryotherapy Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Cryotherapy Market Analysis by Mordor Intelligence

The Cryotherapy Market size is expected to increase from USD 322.04 million in 2025 to USD 339.94 million in 2026 and reach USD 464.61 million by 2031, growing at a CAGR of 6.45% over 2026-2031.

Accelerated replacement of liquid-nitrogen chambers with fully electric systems has started to re-shape cost structures, because clinics shed recurring gas deliveries and ventilation retrofits.[1]CryoBuilt Team, “Polaris Electric Chamber Cuts Five-Year Cost 60%,” CryoBuilt, cryobuilt.com Fitness-club installations, mobile rental fleets, and home devices are widening access beyond sports-medicine clinics, creating fresh demand for consumable-light hardware and software subscriptions. Oncology and pain-management reimbursements in North America provide a medical pathway for localized cryoablation, while aesthetics-oriented spot-cooling devices flourish in cash-pay channels.[2]American Medical Association, “CPT 64624 for Cryoneurolysis,” AMA, ama-assn.org Competitive dynamics emphasize AI-enabled temperature control and throughput optimization rather than ever-lower chamber temperatures, signaling a pivot toward data-rich user experiences.

Key Report Takeaways

  • By product and services, whole-body cryochambers led with 49.13% revenue share in 2025; hybrid and mobile units are projected to post the fastest 10.63% CAGR to 2031.
  • By application, sports recovery accounted for 33.45% share in 2025, while dermatology and aesthetics is forecast to expand at a 9.24% CAGR through 2031.
  • By end user, hospitals and specialty clinics held 43.76% spending share in 2025; home-use and direct-to-consumer devices are expected to grow at a 10.53% CAGR over 2026-2031.
  • By technology, liquid-nitrogen systems commanded 56.84% revenue share in 2025, whereas fully electric platforms are poised for the highest 8.23% CAGR to 2031.
  • By geography, North America dominated with 37.83% revenue share in 2025; Asia-Pacific is anticipated to register the quickest 7.74% CAGR during the forecast period.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Product and Services: Hybrid Units Gain as Rental Fleets Expand

Whole-body cryochambers generated almost half of 2025 revenue, yet hybrid and mobile units will outpace at a 10.63% CAGR as rental operators send trailer-mounted systems to events and corporate campuses. The shift diversifies the cryotherapy market because customers with no capital budget can still provision sessions on demand.

Consumables revenue shrinks as the sector turns electric, but software subscriptions grow when operators use cloud dashboards to schedule sessions, track utilization, and document safety compliance. Localized devices hold roughly 18% share, driven by dermatology uptake for aesthetic spot treatments. Cryosurgery systems, vested mainly in oncology, maintain steady adoption inside interventional radiology suites. Accessories, including nitrogen dewars and thermal gloves, taper in lock-step with the electric transition, so vendors hedge by bundling maintenance contracts and analytics platforms. The evolving mix means chamber form-factors, not temperatures, define competitive advantage, intensifying a platform race across the cryotherapy market.

Cryotherapy Market: Market Share by Product and Services
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Application: Aesthetics Outpace Traditional Recovery

Sports recovery retained 33.45% of the cryotherapy market size in 2025 thanks to elite teams and collegiate programs. Dermatology and aesthetics, however, add sessions faster, climbing 9.24% annually through 2031 on social-media visibility and financing plans.

Pain-management clinics deploy cryoneurolysis probes under CPT 64624, but reimbursement gaps cap statewide rollouts. Oncology usage broadens as imaging-guided cryoablation lowers collateral tissue damage, supporting steady unit placements inside tertiary hospitals. Wellness and weight-management kiosks remain fragmented yet visible in luxury resorts that position cryo as a metabolism booster. The application landscape shows recovery saturation in professional sports, so operators court amateur athletes, beauty seekers, and chronic-pain patients to enlarge the cryotherapy market.

By End User: Home Devices Disrupt Clinic Models

Hospitals and specialty clinics controlled 43.76% of 2025 spending, underpinned by reimbursable cryoneurolysis and oncology cases. Home-use devices, positioned below USD 5,000, clock a double-digit CAGR as affluent consumers bypass per-visit fees.

Sports and fitness centers fold cryo into premium memberships, softening churn in saturated metropolitan gyms. Destination wellness resorts curate multi-day detox packages featuring cold exposure, mindfulness, and IV therapy. The democratization of hardware forces clinics to differentiate through guided protocols, biometric dashboards, and integration with electronic health records, adding data resonance to the cryotherapy market share calculus.

Cryotherapy Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Technology: Electric Systems Erode Nitrogen’s Lead

Liquid-nitrogen systems preserved 56.84% revenue share in 2025 but face attrition as electric chambers mature. Electric units save USD 800-1,200 monthly in gas and skip OSHA ventilation mandates, raising the cryotherapy market size addressable to urban boutique studios.

Practitioners preferring sub-140 °C levels will cling to nitrogen systems in research and elite performance labs. CO₂ spot devices stay niche yet vital in dermatology because they require minimal room prep and cost only USD 2,000-5,000. Regulatory nudges like Germany’s Blue Angel eco-label and California’s Title 24 energy code incentivize electric adoption, plotting a measured but inexorable shift inside the cryotherapy market.

Geography Analysis

North America generated 37.83% of global revenue in 2025, with the United States comprising 85% of that figure on the back of pro-sports demand and early medical reimbursement. Canada and Mexico remain smaller but stable, supporting cash-pay models in Toronto, Vancouver, Monterrey, and Mexico City. FDA clearance of IceCure’s ProSense system for benign breast tumors signals regulatory momentum for minimally invasive cryoablation.

Asia-Pacific will expand the cryotherapy market at 7.74% through 2031 as China’s domestic builders undercut European imports by 30-40%. Japan rides aging-population demand for non-pharmacological pain relief despite absent reimbursement. India’s cricket academies and private hospitals in Mumbai and Bangalore buy chambers to serve professional and affluent amateur athletes. South Korea gravitates toward aesthetics in Seoul’s Gangnam district, while Australia focuses on sports recovery in Sydney and Melbourne. Fragmented rules and cultural preferences for traditional remedies slow uptake, but growing middle-class income and sports participation widen the user base.

In Europe, Germany led, aided by statutory insurers piloting cryo coverage for rheumatoid arthritis. France’s thalassotherapy spas and the United Kingdom’s Premier League clinics maintain robust demand. Italy and Spain add aesthetic and sports-rehab users respectively. Middle East and Africa collectively held about 6% share, dominated by UAE and Saudi Arabia luxury wellness centers. South America’s 5% share is concentrated in Brazil and Argentina, where private hospitals equip orthopedic wards. Together, these regional profiles underline differing adoption curves yet a converging preference for electric, data-rich hardware across the cryotherapy market.

Cryotherapy Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

The cryotherapy market is moderately concentrated. Market leaders pursue vertical integration, as Boston Scientific absorbs probe suppliers for oncology ablation. Medtronic’s cryoablation line added USD 180 million to FY 2025 sales, leveraging hospital relationships and procedure-based billing.

Challengers focus on electric systems that eliminate nitrogen logistics. CryoBuilt and JUKA emphasize sustainability messaging to court eco-certified facilities. Patent trends steer toward AI-controlled temperature algorithms and modular chambers that switch between whole-body and localized modes. Home-use devices below USD 5,000 remain a white-space where incumbents have limited presence. Mobile fleet operators cultivate niche revenue at sporting events and corporate wellness activations, reinforcing a service-led layer within the cryotherapy industry.

Technology differentiation now centers on user-experience features—biometric tracking, smartphone connectivity, and EHR export—rather than ever-colder temperatures. Hospitals demand ISO-compliant logs, whereas consumer segments want gamified recovery metrics. Regulatory divergence sustains two strategic tracks: medical-grade devices chase FDA or CE approval, and wellness brands exploit cash-pay channels aided by influencer marketing. Consolidation pressure likely rises in the medical segment as compliance burdens escalate, but low barriers keep the wellness side fragmented, preserving competitive diversity inside the cryotherapy market.

Cryotherapy Industry Leaders

  1. Zimmer MedizinSysteme GmbH

  2. MECOTEC GmbH

  3. Cryomed s.r.o

  4. Impact Cryotherapy Inc.

  5. CRYO Science

  6. *Disclaimer: Major Players sorted in no particular order
Cryotherapy Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2026: VeCura ReSculpt launched in Hyderabad, pairing non-surgical body sculpting with whole-body cryotherapy.
  • November 2025: CryoTherapeutics partnered with SpectraWAVE and the Cardiovascular Research Foundation on the ICECAP clinical study for coronary plaque treatment.
  • September 2025: Bonphul Air Products debuted Bonphul Cryogen, the first India-manufactured cryotherapy system for clinical and wellness customers.

Table of Contents for Cryotherapy Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Shift from Liquid Nitrogen to Fully-Electric Cryo-Systems Cut Costs
    • 4.2.2 Reimbursement Expansion in Key Regions
    • 4.2.3 Increased Cryo Access in Fitness Clubs
    • 4.2.4 AI-Driven Chambers Enhance Throughput
    • 4.2.5 Rental Market Growth with Mobile Cryo-Vans
    • 4.2.6 Fat-Reduction Demand Spurs Cryo Adoption
  • 4.3 Market Restraints
    • 4.3.1 Rising Gas Prices Increase Risks MXR
    • 4.3.2 Insurer Pushback Due to Lack of Standards Benchmarking Study
    • 4.3.3 Tariffs Impact Mobile Chamber Costs
    • 4.3.4 High Costs Limit Adoption in Small Clinics
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Product and Services
    • 5.1.1 Whole-Body Cryochambers
    • 5.1.2 Localised Devices
    • 5.1.3 Cryosurgery Systems
    • 5.1.4 Hybrid / Mobile Units
    • 5.1.5 Accessories and Conusmables
    • 5.1.6 Software and Services
  • 5.2 By Application
    • 5.2.1 Sports Recovery
    • 5.2.2 Pain Management
    • 5.2.3 Oncology (Cryo-ablation)
    • 5.2.4 Dermatology & Aesthetics
    • 5.2.5 Wellness & Weight-Management
  • 5.3 By End User
    • 5.3.1 Hospitals & Specialty Clinics
    • 5.3.2 Sports & Fitness Centers
    • 5.3.3 Wellness & Spa Facilities
    • 5.3.4 Home-Use / Direct-to-Consumer
  • 5.4 By Technology
    • 5.4.1 Liquid-Nitrogen Systems
    • 5.4.2 Fully-Electric Systems
    • 5.4.3 CO₂ Spot-Therapy Devices
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 France
    • 5.5.2.3 United Kingdom
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 Art of Cryo
    • 6.3.2 Boston Scientific
    • 6.3.3 Brymill Cryogenic Systems
    • 6.3.4 CooperSurgical
    • 6.3.5 Cryo Innovations
    • 6.3.6 CRYO Science
    • 6.3.7 CryoAction
    • 6.3.8 CryoBuilt Inc.
    • 6.3.9 Cryomed s.r.o.
    • 6.3.10 CRYONiQ
    • 6.3.11 Grand Cryo
    • 6.3.12 IceCure Medical
    • 6.3.13 Impact Cryotherapy Inc.
    • 6.3.14 JUKA
    • 6.3.15 KRION
    • 6.3.16 MECOTEC GmbH
    • 6.3.17 Medtronic plc (Cryoablation)
    • 6.3.18 Metrum CryoFlex
    • 6.3.19 Vacuactivus
    • 6.3.20 Zimmer MedizinSysteme GmbH

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Cryotherapy Market Report Scope

As per the scope of the report, Cryotherapy, or "cold therapy," is a therapeutic technique that uses extremely low temperatures to treat tissue lesions, reduce inflammation, alleviate pain, and destroy abnormal tissues like tumors.

The Cryotherapy Market Report is segmented by Product and Services, Application, End User, Technology, and Geography. By Product and Services, the market is segmented into Whole‑Body Cryochambers, Localised Devices, Cryosurgery Systems, Hybrid/Mobile Units, Accessories and Consumables, and Software and Services. By Application, the market is segmented into Sports Recovery, Pain Management, Oncology, Dermatology & Aesthetics, and Wellness & Weight‑Management. By End User, the market is segmented into Hospitals & Specialty Clinics, Sports & Fitness Centers, Wellness & Spa Facilities, and Home‑Use/Direct‑to‑Consumer. By Technology, the market is segmented into Liquid‑Nitrogen Systems, Fully‑Electric Systems, and CO₂ Spot‑Therapy Devices. By Geography, the market is segmented into North America, Europe, Asia‑Pacific, Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. Market Forecasts are Provided in Terms of Value (USD).

By Product and Services
Whole-Body Cryochambers
Localised Devices
Cryosurgery Systems
Hybrid / Mobile Units
Accessories and Conusmables
Software and Services
By Application
Sports Recovery
Pain Management
Oncology (Cryo-ablation)
Dermatology & Aesthetics
Wellness & Weight-Management
By End User
Hospitals & Specialty Clinics
Sports & Fitness Centers
Wellness & Spa Facilities
Home-Use / Direct-to-Consumer
By Technology
Liquid-Nitrogen Systems
Fully-Electric Systems
CO₂ Spot-Therapy Devices
By Geography
North AmericaUnited States
Canada
Mexico
EuropeGermany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-PacificChina
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East & AfricaGCC
South Africa
Rest of Middle East & Africa
South AmericaBrazil
Argentina
Rest of South America
By Product and ServicesWhole-Body Cryochambers
Localised Devices
Cryosurgery Systems
Hybrid / Mobile Units
Accessories and Conusmables
Software and Services
By ApplicationSports Recovery
Pain Management
Oncology (Cryo-ablation)
Dermatology & Aesthetics
Wellness & Weight-Management
By End UserHospitals & Specialty Clinics
Sports & Fitness Centers
Wellness & Spa Facilities
Home-Use / Direct-to-Consumer
By TechnologyLiquid-Nitrogen Systems
Fully-Electric Systems
CO₂ Spot-Therapy Devices
By GeographyNorth AmericaUnited States
Canada
Mexico
EuropeGermany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-PacificChina
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East & AfricaGCC
South Africa
Rest of Middle East & Africa
South AmericaBrazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How fast will global cryotherapy revenues grow through 2031?

The cryotherapy market is forecast to expand at a 6.45% CAGR from 2026 to 2031, reaching USD 464.61 million.

Which technology is replacing liquid-nitrogen chambers?

Fully electric systems are growing at an 8.23% CAGR because they eliminate gas costs and meet sustainability mandates.

What segment holds the largest cryotherapy market share today?

Whole-body cryochambers led with 49.13% share in 2025.

Where is regional growth strongest after North America?

Asia-Pacific is projected to post a 7.74% CAGR through 2031, buoyed by lower-cost domestic manufacturers in China.

Are home cryotherapy devices economically viable for consumers?

Yes, devices priced below USD 5,000 can break even after 30-50 sessions compared with clinic fees.

What is the key reimbursement milestone for cryoneurolysis?

AMA CPT 64624, introduced in 2024, allows U.S. providers to bill Medicare and private insurers for peripheral-nerve cryoablation.

Page last updated on:

Cryotherapy Market Report Snapshots